Offering finalized, ReNeuron Group plc (LON: RENE)
RENE finalized the shareholder approvals necessary to permit the allotment and the issue of the remaining 95,533,498 of the recent placement.
Referencing our blog of 12/13/10:
The 3rd tranche was allotted, subject only to admission. Application has been made to the LSE to be admitted to trading on AIM to become effective 12/30/10.
- The total number of issued shares of RENE is 619,849,289 Shares.
Categories: Financing, ReNeuron (LON: RENE), Stem Cell Technology







